InMode Ltd. (NASDAQ:INMD) spotted trading -69.43% off 52-week high price. On the other end, the stock has been noted 37.52% away from the low price over the last 52-weeks. The stock changed 4.06% to recent value of $17.96. The stock transacted 957322 shares during most recent day however it has an average volume of 1.69M shares. The company has 28.92M of outstanding shares and 22.52M shares were floated in the market.
On March 23,2020, InMode Ltd. (NASDAQ:INMD) a leading global provider of innovative medical technologies, provided an update regarding its business activities in light of the ongoing global health situation caused by the COVID-19. As of, InMode’s Q1 2020 revenue from devices and consumables is in line with its target. Based on the company’s strong position for continued growth once the COVID-19 has subsided, and since InMode does not have visibility for the coming months, at this time InMode management has decided not to adjust its 2020 guidance. The company will continue to monitor the situation.
InMode is currently maintaining its business activities as usual, with minimal impact to sales and manufacturing activities. The company is continuing research and development into new platforms and indications, in addition to furthering the regulatory processes for devices and indications worldwide. InMode continues to strengthen its supply chain, in order to ensure continued stability with respect to manufacturing capacity and reliable inventory. In addition, InMode continues to strengthen its worldwide distribution network. These activities include the establishment of a fully owned subsidiary for sales and marketing in France.
InMode is strongly positioned to weather the uncertainty of the current global economic situation, commented Moshe Mizrahy, CEO of InMode. We are supporting our customers during these extraordinary circumstances, and we will do everything in our power to maintain customer loyalty during and after this period. Based on management’s confidence in the company’s growth potential, we are currently evaluating several near-term actions, which may include, among other things, a stock repurchase program after the blackout period.
Its earnings per share (EPS) expected to touch remained 165.90% for this year while earning per share for the next 5-years is expected to reach at 13.80%. INMD has a gross margin of 87.10% and an operating margin of 22.70% while its profit margin remained 22.00% for the last 12 months.
According to the most recent quarter its current ratio was 7.8 that represents company’s ability to meet its current financial obligations. The price moved ahead of -32.04% from the mean of 20 days, -51.63% from mean of 50 days SMA and performed -47.05% from mean of 200 days price. Company’s performance for the week was 13.38%, -53.95% for month and YTD performance remained -54.18%.